𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of in vivo correction of defined mismatches in the DNA mismatch repair mutants msh2, msh3 and msh6 of Saccharomyces cerevisiae

✍ Scribed by Lühr, B. ;Scheller, J. ;Meyer, P. ;Kramer, W.

Publisher
Springer
Year
1998
Tongue
English
Weight
155 KB
Volume
257
Category
Article
ISSN
0026-8925

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Promoter methylation and expression of M
Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas
✍ Jörg Felsberg; Niklas Thon; Sabina Eigenbrod; Bettina Hentschel; Michael C. Sabe 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 534 KB

## Abstract Epigenetic silencing of the O^6^‐methylguanine‐DNA methyltransferase (__MGMT__) gene promoter is associated with prolonged survival in glioblastoma patients treated with temozolomide (TMZ). We investigated whether glioblastoma recurrence is associated with changes in the promoter methyl

Molecular characterization of the spectr
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC)
✍ Heleen van der Klift; Juul Wijnen; Anja Wagner; Paul Verkuilen; Carli Tops; Roby 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 577 KB

## Abstract A systematic search by Southern blot analysis in a cohort of 439 hereditary nonpolyposis colorectal cancer (HNPCC) families for genomic rearrangements in the main mismatch repair (MMR) genes, namely, __MSH2__, __MLH1__, __MSH6__, and __PMS2__, identified 48 genomic rearrangements causat

p53 status correlates with the different
p53 status correlates with the differential expression of the DNA mismatch repair protein MSH2 in non-small cell lung carcinoma
✍ George Xinarianos; Triantafillos Liloglou; Wendy Prime; George Sourvinos; Andrea 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 855 KB

We examined the p53 status of 108 NSCLCs compared to the expression of MLH1 and MSH2 proteins. p53 overexpression was demonstrated by IHC in 64% of patients examined, whereas p53 mutations were detected in 43%. Twenty-two percent of mutations were located outside of the hot-spot (exons 5-8) area. p5